Oaktree Acquisition Corp. II (OACC)
Stock analysis · NASDAQ · Financial Services · Shell Companies
Oaktree Acquisition Corp. II (OACC) is a publicly traded company in the Financial Services sector. Latest price: $10.72. Market cap $263.53M. Trailing PE 37.91. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Proprietary Signals
About Oaktree Acquisition Corp. II
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Valuation
| P/E (TTM) | 37.91× |
|---|---|
| P/S (TTM) | 0.00× |
| P/B | 1.04× |
| PEG | 0.95× |
| P/FCF (TTM) | -578.31× |
| EV / EBITDA | -218.71× |
| EV / Sales | 0.00× |
| Earnings Yield | 3.28% |
| Free Cash Flow Yield | -0.17% |
Fundamentals
| Enterprise Value | $262.36M |
|---|---|
| Net Income (TTM) | $8.65M |
| Free Cash Flow (TTM) | -$455.69K |
| Net Debt | -$1.17M |
| Working Capital | -$469.90K |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
| Return on Equity | 3.46% |
| Return on Invested Capital | -0.59% |
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap